medigraphic.com
ISSN 1028-4796 (Print)

2011, Number 4

<< Back Next >>

Rev Cubana Plant Med 2011; 16 (4)

Antibacterial activity and in vivo cytotoxicity of ethanol extracts from Bauhinia variegata L. (Fabaceae)

Martínez MM, Ocampo DM, Galvis JH, Valencia A

Language: Spanish
References: 41
Page: 313-323
PDF size: 104.70 Kb.


ABSTRACT

Introduction: several research studies have identified the biological potential of different compounds such as flavonoids, tannins, steroids, naphtoquinones and sesquiterpenoid present in the genus Bauhinia. It has been reported for the species B. variegata the presence of flavonoids with anti-diabetic and antiviral properties, but the study of antibiotic and cytotoxic potential is just incipient for both flavonoid and alkaloid compounds.
Objective: to determine the antibacterial and in vivo cytotoxic activity of alkaloid extracts from Bauhinia variegata L.
Methods: column chromatography for extraction and isolation of alkaloids in B. variegata.leaves was performed. Alkaloid extracts and fractions were tested through bioassay for their cytotoxic potential on "brine shrimp" (Artemia salina) and the antibacterial potential on Escherichia coli through the disk diffusion method (antibiogram by diffusion).
Results: six compounds were purified and measured the presence of the protoberberinic nucleus by means of UV spectrophotometry. Regarding Artemia salina bioassay, the crude extract (CE) showed less toxicity (LC50> 1000 µg/mL), whereas the fraction of the total alkaloid fraction (TA) and the CD1 compound showed high toxicity (LC50< 500 µg/mL). Unlike the evidence for the antimicrobial bioassay, no inhibition zones for treatment with the extracts and the compounds appeared.
Conclusions: the reported cytotoxic activity is caused by the synergistic effect of all secondary metabolites that could occur in the plant, which were also associated with this activity (alkaloids and terpenes) that account for the toxicity shown by the total alkaloid fraction.


REFERENCES

  1. Meyer BM, Ferrigni NR, Putman JE, Jacobsen LB, Nichols DE, McLaughlin JL. Brine shrimp: A convenient general bioassay for active plant constituents. Planta Med. 1982;45:31-4.

  2. Lewan L, Andersson M, Morales-Gómez P. The use of Artemia salina in toxicity test. ATLA. 1992;20:297-301.

  3. Payrol JA, Martínez MM, Carrabeo GT, García CO. Actividad farmacológica preliminar del fruto de Bromelia pinguin L. (piña de ratón). Rev Cubana Farm. 2001;35:56-60.

  4. Winûeld MD, Groisman EA. Role of non-host environments in the lifestyles of Salmonella and Escherichia coli. Appl Environ Microbiol. 2003;69:3687-94.

  5. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123-40.

  6. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. CMR 1998;11:142-201.

  7. Sanabria-Galindo A, López SI, Gualdron R. Estudio fitoquímico preliminar y letalidad sobre Artemia salina de plantas colombianas. Rev Col Cienc Quim Farm. 1997;26:15-9.

  8. Russo EMK, Reichelt AAJ, De-Sa JR, Furlanetto RP, Moises RCS, Kasamatsu TS, et al. Clinical trial of Myrcia uniflora and Bauhinia forficata leaf extracts in normal and diabetic patients. Braz J Med Biol Res. 1990;23:11-20.

  9. Soares J, Costa S, Cecim M. Níveis glicêmicos de colesterol em ratos com diabetes melittus aloxano induzido, tratados com infusão de Bauhinia candicans ou Syzygium jambolanum. Ciência Rural. 2000;30:113-8.

  10. Da Silva ML, Filho VC. Plantas do gênero Bauhinia: Composição química e potencial farmacológico. Química nova. 2002;25:449-54.

  11. Damasceno DC, Volpato GT, Mattos I, Calderon P, Aguilar R, Cunha-Rudge MV. Effect of Bauhinia forficate extracts in diabetic pregnant rats: maternal repercussions. Phytomedicine. 2004;11:196-201.

  12. Gupta M, Mazumder UK, Sambath K, Gomathi P, Rajeshwar Y, Kakoti BB, Tamil-Selven V. Antiinflammatory, analgesic and antipyretic effects of methanol extract from B. racemosa stem bark in animal models. J Ethnopharmacol. 2005;98:267-73.

  13. Murillo E, Tique MM, Ospina LF, Lombo Ó. Evaluación preliminar de la actividad hipoglicemiante en ratones diabéticos por aloxano y capacidad antioxidante in vitro de extractos de Bauhinia kalbreyeri Harms. Rev Col Cienc Quím Farm. 2006;35:64- 80.

  14. Yadava RN, Reddy VM. Anti-inflammatory activity of a novel flavonol glycoside from the Bauhinia variegate Linn. Nat Prod Res. 2003;17:165-9.

  15. Pokhrel NR, Adhikari RP, Baral MP. In vitro evaluation of the antimicrobial activity of Bauhinia variegata, locally known as Koiralo. World J Microbiol Biotechnol. 2002;18:69-71.

  16. Achenbach H, Stocker M, Constenla MAF. Flavonoid and other constituents of Bauhinia manca. Phytochemistry. 1988;27:1835-41.

  17. Iribarren AM, Pomilio AB. Components of Bauhinia candicans. J Nat Prod. 1983;46:752-3.

  18. Iribarren AM, Pomilio AB. Steroidal glycosides, flavonoids and other components of Bauhinia uruguayensis. Assoc Quim Argent. 1989;77:461-6.

  19. Yadava RN, Tripathi P. A novel flavone glycoside from the stem of Bauhinia purpurea. Fitoterapia. 2000,71:88-90.

  20. Silva KL, Biavatti MW, Leite SN, Yunes RA, Delle-Monache F, Cechinel-Filho VZ. Phytochemical and pharmacognositc investigation of Bauhinia forficata L. (Leguminosae) Z. Naturforsch. 2000,55:478-80.

  21. Cechinel-Filho V, Breviglieri E, Willain-Filho A, Santos ARS. Estudo fitoquímico e avaliação preliminar da atividade analgésica de Bauhinia splendens. Rev Bras Farm. 1995,76:115-7.

  22. Da Silva ML, Filho VC. Plantas do gênero Bauhinia: Composição química e potencial farmacológico. Química nova. 2002;25:449-54.

  23. Gil-Otaiza R. Plantas usuales en la medicina popular venezolana. Mérida. Venezuela: Editorial Universidad de Los Andes; 1997.

  24. Lock O. Investigación fitoquímica: Métodos en el estudio de productos naturales. Lima, Perú: Fondo editorial; 1994.

  25. McLaughlin J, Colman-Saizarbitoria T, Anderson J. Tres bioensayos simples para químicos de productos naturales. Rev Soc Ven Quim. 1995;18:13-21.

  26. Finney DL. Statistical method in biological assay. London: High Wycombe; 1978.

  27. Murray PR, Baron M, Pfaller A, Tenover R, Yolke H. Manual of clinical microbiology. Washington, DC.: ASM; 1995.

  28. National Commettee for Clinical Laboratory Standards (NCCLS). Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved Standard. Villanova, PA; 2001.

  29. National Commettee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A3. Villanova, PA; 1993.

  30. National Commettee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test. Approved standard M2-A5; 1993.

  31. Müeller J, Hinton J. A protein free medium for primary isolation of Gocococcus and Meningococcus. Proc Soc Esp Biol Med. 1941;48:330-3.

  32. Bauer AL, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disc method. Am J Clin Pathol. 1966;45:493-6.

  33. McFarland J. Nephelometer. J Am Med Assoc. 1907;14:1176-8.

  34. Rojas A, Hernández L. Screening for antimicrobial activity of crude drugs extracts and pure natural form Mexican medicial plants. J Ethnopharmacol. 1992;35:275-83.

  35. Arroyo G. Determinación químico-bromatológica y actividad antimicrobiana de Spondias mombi L. (Ubo). Ciencia e Investigación. 2000;3:59-62.

  36. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters 2011-01-05 (v 1.3).[ (cited Mar 30 2011).] Available in: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documen ts/EUCAST_breakpoints_v1.3_pdf.pdf

  37. Shamma M. The isoquinoline alkaloids: Chemistry and Pharmacology. Verlag Chemie, NY: Academic Press; 1972.

  38. Bernal HY, Correa JE. Especies vegetales promisorias de los países del convenio Andrés Bello. Bogotá, Colombia: Editorial SECAB; 1989.

  39. Abbasoglu U, Sener B, Gunay Y, Temizer H. Antimicrobial activity of some isoquinoline alkaloids. Archiv de Pharmazie. 1991;324:379-80.

  40. Paulo MQ, Barbosa-Folho JM, Lima EO, Maia RF, Barbosa RC, Kaplan MA. Antimicrobial activity of benzylisoquinoline alkaloids from Annona salzmanii. J Ethnopharmacol. 1992;36:39-41.

  41. Suffredini IB, Sader HS, Gonçalves AG, Reis AO, Varella AD, Younes RN. Screening of antibacterial extracts from plants to the Brazilian Amazon rain forest and Atlantic forest. Braz J Med Biol Res. 2004;37:379-84.




2020     |     www.medigraphic.com